NKE
36
2
AMT
30
2
XOM
33
3
ORCL
49
3
SPG
45
2
MMC
46
5
DUK
49
4
KIM
58
2
PNW
55
3
DGX
28
4
ADI
54
4
STX
34
2
CME
59
3
HCA
37
7
INTC
35
4
BMY
40
-5
CHRW
53
2
ABT
54
4
LNC
28
3
UAL
73
3
NKE
36
2
AMT
30
2
XOM
33
3
ORCL
49
3
SPG
45
2
MMC
46
5
DUK
49
4
KIM
58
2
PNW
55
3
DGX
28
4
ADI
54
4
STX
34
2
CME
59
3
HCA
37
7
INTC
35
4
BMY
40
-5
CHRW
53
2
ABT
54
4
LNC
28
3
UAL
73
3
Financhill
Back

BioNTech SE 10K Form

Sell
36

BNTX
BioNTech SE

Last Price:
$113.18
Seasonality Move:
15.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $4.1B
Cash Flow: $-770.2M
Price / Cash Flow: 26.48
Annual Sales: $89.05
Price / Book: 1.27

Profitability

EPS (TTM): -2.11460
Net Income (TTM): $-501.1M
Gross Margin: $3.5B
Return on Equity: -2.35%
Return on Assets: -2.06%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 7 years for BNTX is 84.29%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 14.60% of Gross Profit Margin.
  • The Research & Development expenses have been 46.69% of Revenue.
  • The Interest Expense is 0.17% of Operating Income.
  • The Net Earning history of BNTX is 24.36% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 7.33
Quick Ratio: 7.1

Price-to-Earnings

Trailing P/E Ratio: 27.27
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
36
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $113.08. The Score for BNTX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.